Here are the 10-K annual reports from Hyperfine, Inc. (HYPR) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow HYPR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HYPR filings page.
Hyperfine, Inc. reports on its business as an early-stage health technology company focused on AI-powered, ultra-low-field portable brain MRI. Its flagship Swoop® Portable MR Imaging® System brings bedside brain imaging to hospitals and neurology offices using a 0.064T permanent magnet and Optive AI™ software.
The company targets more than $16 billion in potential U.S. device placements, selling systems with recurring software, service and support agreements. It emphasizes multiple FDA 510(k) clearances, CE Mark, UKCA Mark and Indian approval, a portfolio of 197 issued patents and 160 pending applications, and a strategy spanning U.S. hospitals, neurology offices and international distributors.
Hyperfine highlights significant risks, including a history of net losses, ongoing capital needs, dependence on market adoption, single-source manufacturing for key components, extensive healthcare regulation, cybersecurity and data-privacy exposure, controlled-company governance, and concentrated voting power with founder Jonathan M. Rothberg, Ph.D.